Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (531-540 of 684) with videos related to

Pageof 69
Sort By:
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
International Journal of Epidemiology|June 19, 2019
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization studyHolly R Harris, Kara L Cushing-Haugen, Penelope M Webb, et al.
American Journal of Epidemiology|December 13, 2016
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control StudiesChristina B Rasmussen, Susanne K Kjaer, Vanna Albieri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Cancer Research|June 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune ResponseJacob E Berchuck, Elio Adib, Sarah Abou Alaiwi, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Cancer|June 17, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancerShehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Pageof 69

Showing results (531-540 of 684) with videos related to

Sort By:
Pageof 69
Epidemiology (Cambridge, Mass.)|February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship ExploredAlice W Lee, Anna H Wu, Ashley Wiensch, et al.
International Journal of Epidemiology|June 19, 2019
Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization studyHolly R Harris, Kara L Cushing-Haugen, Penelope M Webb, et al.
American Journal of Epidemiology|December 13, 2016
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control StudiesChristina B Rasmussen, Susanne K Kjaer, Vanna Albieri, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2019
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K Armstrong, Ronald D Alvarez, Jamie N Bakkum-Gamez, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Cancer Research|June 22, 2022
The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune ResponseJacob E Berchuck, Elio Adib, Sarah Abou Alaiwi, et al.
International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.
Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.
Cancer|June 17, 2024
Insulin resistance during androgen deprivation therapy in men with prostate cancerShehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, et al.
Journal of the National Cancer Institute|July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancerMinh Tung Phung, Alice W Lee, Karen McLean, et al.
Pageof 69